Literature DB >> 25279927

Kruidenier et al. reply.

Laurens Kruidenier1, Chun-wa Chung2, Zhongjun Cheng3, John Liddle1, KaHing Che4, Gerard Joberty5, Marcus Bantscheff5, Chas Bountra6, Angela Bridges2, Hawa Diallo1, Dirk Eberhard5, Sue Hutchinson2, Emma Jones2, Roy Katso2, Melanie Leveridge2, Palwinder K Mander1, Julie Mosley2, Cesar Ramirez-Molina1, Paul Rowland2, Christopher J Schofield6, Robert J Sheppard1, Julia E Smith1, Catherine Swales7, Robert Tanner2, Pamela Thomas2, Anthony Tumber6, Gerard Drewes5, Udo Oppermann4, Dinshaw J Patel3, Kevin Lee8, David M Wilson1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25279927     DOI： 10.1038/nature13689

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  2 in total

1.  Inhibition of demethylases by GSK-J1/J4.

Authors:  Bo Heinemann; Jesper Morten Nielsen; Heidi Rye Hudlebusch; Michael J Lees; Dorthe Vang Larsen; Thomas Boesen; Marc Labelle; Lars-Ole Gerlach; Peter Birk; Kristian Helin
Journal:  Nature       Date:  2014-10-02       Impact factor: 49.962

2.  A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response.

Authors:  Laurens Kruidenier; Chun-wa Chung; Zhongjun Cheng; John Liddle; KaHing Che; Gerard Joberty; Marcus Bantscheff; Chas Bountra; Angela Bridges; Hawa Diallo; Dirk Eberhard; Sue Hutchinson; Emma Jones; Roy Katso; Melanie Leveridge; Palwinder K Mander; Julie Mosley; Cesar Ramirez-Molina; Paul Rowland; Christopher J Schofield; Robert J Sheppard; Julia E Smith; Catherine Swales; Robert Tanner; Pamela Thomas; Anthony Tumber; Gerard Drewes; Udo Oppermann; Dinshaw J Patel; Kevin Lee; David M Wilson
Journal:  Nature       Date:  2012-08-16       Impact factor: 49.962
  2 in total
  8 in total

Review 1.  Epigenetic modification in chromatin machinery and its deregulation in pediatric brain tumors: Insight into epigenetic therapies.

Authors:  Eleonore Maury; Rintaro Hashizume
Journal:  Epigenetics       Date:  2017-01-06       Impact factor: 4.528

Review 2.  Histone Methylation Regulation in Neurodegenerative Disorders.

Authors:  Balapal S Basavarajappa; Shivakumar Subbanna
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

Review 3.  Chemical probes targeting epigenetic proteins: Applications beyond oncology.

Authors:  Suzanne Ackloo; Peter J Brown; Susanne Müller
Journal:  Epigenetics       Date:  2017-01-12       Impact factor: 4.528

4.  KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer.

Authors:  Zhi Cao; Xiaolei Shi; Feng Tian; Yu Fang; Jason Boyang Wu; Stefan Mrdenovic; Xinwen Nian; Jin Ji; Huan Xu; Chen Kong; Yalong Xu; Xi Chen; Yuhua Huang; Xuedong Wei; Yongwei Yu; Bo Yang; Leland W K Chung; Fubo Wang
Journal:  Cell Death Dis       Date:  2021-01-06       Impact factor: 8.469

5.  A KDM6 inhibitor potently induces ATF4 and its target gene expression through HRI activation and by UTX inhibition.

Authors:  Shojiro Kitajima; Wendi Sun; Kian Leong Lee; Jolene Caifeng Ho; Seiichi Oyadomari; Takashi Okamoto; Hisao Masai; Lorenz Poellinger; Hiroyuki Kato
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

6.  UTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemia.

Authors:  Aissa Benyoucef; Carmen G Palii; Chaochen Wang; Christopher J Porter; Alphonse Chu; Fengtao Dai; Véronique Tremblay; Patricia Rakopoulos; Kulwant Singh; Suming Huang; Francoise Pflumio; Josée Hébert; Jean-Francois Couture; Theodore J Perkins; Kai Ge; F Jeffrey Dilworth; Marjorie Brand
Journal:  Genes Dev       Date:  2016-03-01       Impact factor: 11.361

7.  The TrxG Complex Mediates Cytokine Induced De Novo Enhancer Formation in Islets.

Authors:  Bryan R Tennant; Peter Hurley; Jasmine Dhillon; Amol Gill; Cheryl Whiting; Brad G Hoffman
Journal:  PLoS One       Date:  2015-10-27       Impact factor: 3.240

8.  Challenges in validating candidate therapeutic targets in cancer.

Authors:  Jeffrey Settleman; Charles L Sawyers; Tony Hunter
Journal:  Elife       Date:  2018-02-08       Impact factor: 8.140
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.